CRISPR Therapeutics maintains its primary United States corporate operational headquarters and advanced research laboratories in Cambridge, Massachusetts. Situated directly within the vibrant biotechnology and pharmaceutical hub of the Greater Boston area, this facility serves as the strategic center for its clinical development programs, regulatory affairs, corporate partnerships, and pioneering gene-editing research initiatives, complementing its international legal headquarters located in Zug, Switzerland.